SYT12: Synaptotagmin 12 Gene

A calcium sensor involved in vesicle trafficking and neurotransmitter release

Gene Information Card

Symbol SYT12
Full Name Synaptotagmin 12
Gene Type Protein coding
Chromosomal Location 11q13.1
NCBI Gene ID 91683 ncbi.nlm.nih.gov/gene/91683
Ensembl ID ENSG00000173207
UniProt ID Q8IV01
OMIM ID 609679
HGNC ID 19248
Aliases SRG1, sytXII

Description

SYT12 (synaptotagmin 12) encodes a member of the synaptotagmin family, which are calcium sensors involved in membrane trafficking and exocytosis. SYT12 is predominantly expressed in the brain and plays a role in regulating neurotransmitter release, synaptic vesicle recycling, and calcium-dependent membrane fusion. It is also implicated in certain cancers and neurological conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer SYT12 overexpression may promote tumor cell migration and invasion through altered calcium signaling and vesicle trafficking. COSMIC; PMID: 25691885
Glioma SYT12 is upregulated in glioblastoma and associated with poor prognosis, potentially via modulation of synaptic-like vesicle release in tumor cells. COSMIC; PMID: 29187737
Schizophrenia SYT12 variants have been linked to altered synaptic function and neurotransmitter release, contributing to disease risk. ClinVar; PMID: 23933820

Expression Profile

Tissue Expression
Tissue nTPM level
Brain (cerebral cortex) 12.5 Medium
Brain (cerebellum) 10.2 Medium
Testis 3.1 Low
Lung 1.8 Low
Liver 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.3 Neuronal model; high expression
U87MG (glioblastoma) 8.7 Cancer cell line; moderate expression
MCF7 (breast cancer) 4.2 Low expression
HEK293 (embryonic kidney) 0.9 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.01% Unknown; predicted damaging by SIFT
c.1420G>A (p.Glu474Lys) Missense <0.01% Unknown; predicted benign
c.1762_1763insA (p.Thr588Asnfs*2) Frameshift <0.01% Loss of function; truncation
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Thr588Asnfs*2) are predicted to cause loss of function by truncating the C-terminal C2 domain, impairing calcium binding and vesicle fusion.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in SYT12.

Dominant Negative (DN)

No dominant-negative mutations described for SYT12.

Pathways

Synaptic vesicle cycle (KEGG: hsa04721)
Calcium signaling pathway (KEGG: hsa04020)
Neurotransmitter release cycle (Reactome: R-HSA-112310)

Protein Summary

Synaptotagmin 12 is a 588-amino acid protein with an N-terminal transmembrane domain and two C-terminal C2 domains (C2A and C2B) that bind calcium and phospholipids. It localizes to synaptic vesicle membranes and regulates calcium-triggered exocytosis. Unlike other synaptotagmins, SYT12 may have both calcium-dependent and calcium-independent functions, modulating vesicle trafficking in neurons and potentially in cancer cells.

Related Products

Product name Cat.No. Species Gene ID
SYT12 Knockout HEK293 Cell Line EDJ-KQ10773 Human 91683 Details Get a Quote
SYT12 Knockout A-549 Cell Line EDJ-KQ37093 Human 91683 Details Get a Quote
SYT12 Knockout HCT 116 Cell Line EDJ-KQ38387 Human 91683 Details Get a Quote
SYT12 Knockout HeLa Cell Line EDJ-KQ38388 Human 91683 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: